Reprogramming the immune system using antibodies.

Reprogramming the immune system using antibodies.

Tolerance induction induced by monoclonal antibodies or co-receptor blockade is robust enough to resist breakdown by adoptive transfer of lymphocytes. Such resistance, the hallmark of dominant tolerance, is mediated by CD4+ regulatory T cells. CD4+CD25+ T cells inhibit lymphopenia-mediated accumulat...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Graca, L, Waldmann, H
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2006

समान संसाधन

Reprogramming the immune system for tolerance with monoclonal antibodies.
द्वारा: Cobbold, S, और अन्य
प्रकाशित: (1990)

Reprogramming the immune system.
द्वारा: Waldmann, H
प्रकाशित: (2008)

Reprogramming the immune system.
द्वारा: Waldmann, H
प्रकाशित: (2002)

REPROGRAMMING THE IMMUNE-SYSTEM
द्वारा: Waldmann, H, और अन्य
प्रकाशित: (1993)

Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies.
द्वारा: Cobbold, S, और अन्य
प्रकाशित: (1992)

Prospects for reprogramming the immune system in multiple sclerosis
द्वारा: Waldmann, H
प्रकाशित: (2007)

Reprogramming the immune system towards regulation
द्वारा: Waldmann, H, और अन्य
प्रकाशित: (2010)

Reprogramming the immune system: co-receptor blockade as a paradigm for harnessing tolerance mechanisms.
द्वारा: Waldmann, H, और अन्य
प्रकाशित: (2008)

Reprogramming the immune system: a possible therapeutic approach to established autoimmune disease.
द्वारा: Waldmann, H, और अन्य
प्रकाशित: (1993)

INTERACTION OF MONOCLONAL-ANTIBODIES WITH THE IMMUNE-SYSTEM
द्वारा: Clark, M, और अन्य
प्रकाशित: (1986)

Antibody-induced transplantation tolerance: the role of dominant regulation.
द्वारा: Graca, L, और अन्य
प्रकाशित: (2003)

Similarities in the Metabolic Reprogramming of Immune System and Endothelium
द्वारा: Chu-Yik Tang, और अन्य
प्रकाशित: (2017-07-01)

GPC2 antibody–drug conjugate reprograms the neuroblastoma immune milieu to enhance macrophage-driven therapies
द्वारा: Paul M Sondel, और अन्य
प्रकाशित: (2022-12-01)

Human monoclonal antibodies: the residual challenge of antibody immunogenicity.
द्वारा: Waldmann, H
प्रकाशित: (2014)

Cutting edge: anti-CD154 therapeutic antibodies induce infectious transplantation tolerance.
द्वारा: Graca, L, और अन्य
प्रकाशित: (2000)

The use of monoclonal antibodies to achieve immunological tolerance.
द्वारा: Waldmann, H, और अन्य
प्रकाशित: (1993)

The use of monoclonal antibodies to achieve immunological tolerance.
द्वारा: Waldmann, H, और अन्य
प्रकाशित: (1993)

Immunotherapy of Cancer: Reprogramming Tumor-Immune Crosstalk
द्वारा: Kyle K. Payne, और अन्य
प्रकाशित: (2012-01-01)

Understanding and Modulating Immunity With Cell Reprogramming
द्वारा: Cristiana F. Pires, और अन्य
प्रकाशित: (2019-12-01)

The cancer metabolic reprogramming and immune response
द्वारा: Longzheng Xia, और अन्य
प्रकाशित: (2021-02-01)

MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
द्वारा: Mathieson, P, और अन्य
प्रकाशित: (1990)

Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity
द्वारा: Ping Cheng, और अन्य
प्रकाशित: (2024-12-01)

Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies.
द्वारा: O'Neill, J, और अन्य
प्रकाशित: (1993)

Lipid Metabolism Reprogramming of Immune Cells in Acne: An Update
द्वारा: Wu S, और अन्य
प्रकाशित: (2023-09-01)

Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma
द्वारा: Songlei Zhou, और अन्य
प्रकाशित: (2023-01-01)

Prospects for the application of antibodies in medicine.
द्वारा: Waldmann, H
प्रकाशित: (2000)

SIRPα antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironment
द्वारा: Defeng Kong, और अन्य
प्रकाशित: (2022-10-01)

Regulation of Immune Cell Functions by Metabolic Reprogramming
द्वारा: Jaehong Kim
प्रकाशित: (2018-01-01)

Targeting macrophages to reprogram the tumor immune microenvironment
द्वारा: Zhidong Xie, और अन्य
प्रकाशित: (2024-10-01)

Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma
द्वारा: Huimei Huang, और अन्य
प्रकाशित: (2021-09-01)

Polylactide Degradation Activates Immune Cells by Metabolic Reprogramming
द्वारा: Chima V. Maduka, और अन्य
प्रकाशित: (2023-11-01)

Impact of epigenetic reprogramming on antitumor immune responses in glioma
द्वारा: Brandon L. McClellan, और अन्य
प्रकाशित: (2023-01-01)

Manipulation of T-cell responses with monoclonal antibodies.
द्वारा: Waldmann, H
प्रकाशित: (1989)

The major histocompatibility system and the immune response.
द्वारा: Munro, A, और अन्य
प्रकाशित: (1978)

Hybrid antibodies for therapy.
द्वारा: Clark, M, और अन्य
प्रकाशित: (1988)

Limiting dilution analysis of the cells of immune system I. The clonal basis of the immune response.
द्वारा: Lefkovits, I, और अन्य
प्रकाशित: (1984)

THERAPY WITH HYBRID ANTIBODIES
द्वारा: Clark, M, और अन्य
प्रकाशित: (1989)

Monoclonal antibodies for organ transplantation: prospects for the future.
द्वारा: Waldmann, H
प्रकाशित: (1988)

TOLERANCE INDUCTION USING CD4 AND CD8 MONOCLONAL-ANTIBODIES
द्वारा: Waldmann, H, और अन्य
प्रकाशित: (1989)

Human placental exosomes induce maternal systemic immune tolerance by reprogramming circulating monocytes
द्वारा: Kunfeng Bai, और अन्य
प्रकाशित: (2022-02-01)